<DOC>
	<DOC>NCT02806362</DOC>
	<brief_summary>The purpose of this multicenter, single-arm, combination-drug study, which includes 12 weeks of treatment and 24 weeks of follow-up, is to evaluate the safety, efficacy and pharmacokinetics of ombitasvir/paritaprevir/ritonavir in Japanese adults infected with HCV GT1b, who are treatment-na√Øve or treatment-experienced to an IFN-based regimen and who have ESRD on HD.</brief_summary>
	<brief_title>Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD)</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<criteria>Females must be practicing specific forms of birth control on study treatment, or be postmenopausal for more than 2 years or surgically sterile Hepatitis C Virus (HCV) Ribonucleic acid (RNA) greater than 10,000 IU/mL at Screening Chronic HCV, Genotype (GT)1b infection Treatmentnaive or treatmentexperienced with an interferon (IFN)containing regimen (IFN or pegylatedIFN with or without ribavirin). A fibrosis assessment test result equivalent to Metavir F0F2. Presence of Y93H variant at Screening Positive test result for Hepatitis B surface antigen (HBsAg) or antiHuman immunodeficiency virus antibody (HIV Ab) Significant liver disease with any cause other than chronic HCV infection On peritoneal dialysis On hemodialysis for more than 15 years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Non-cirrhotic</keyword>
	<keyword>End Stage Renal Disease (ESRD)</keyword>
	<keyword>moderate fibrosis</keyword>
	<keyword>Chronic Hepatitis C Virus ( HCV)</keyword>
	<keyword>Chronic Hepatitis C Genotype 1b</keyword>
</DOC>